CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 55018-55211 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T490","span":{"begin":0,"end":193},"obj":"Sentence"},{"id":"T88177","span":{"begin":0,"end":193},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"PVL-positive CA-MRSA, which were initially susceptible to most antistaphylococcal antibiotics, have acquired new antibiotic resistance determinants, to gentamicin and ofloxacin for instance. v."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T48","span":{"begin":0,"end":193},"obj":"Sentence"}],"text":"PVL-positive CA-MRSA, which were initially susceptible to most antistaphylococcal antibiotics, have acquired new antibiotic resistance determinants, to gentamicin and ofloxacin for instance. v."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T137","span":{"begin":0,"end":3},"obj":"Disease"},{"id":"T138","span":{"begin":16,"end":20},"obj":"Disease"},{"id":"T37916","span":{"begin":0,"end":3},"obj":"Disease"},{"id":"T37559","span":{"begin":16,"end":20},"obj":"Disease"}],"attributes":[{"id":"A137","pred":"mondo_id","subj":"T137","obj":"http://purl.obolibrary.org/obo/MONDO_0015742"},{"id":"A138","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A48900","pred":"mondo_id","subj":"T37916","obj":"http://purl.obolibrary.org/obo/MONDO_0015742"},{"id":"A62953","pred":"mondo_id","subj":"T37559","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"PVL-positive CA-MRSA, which were initially susceptible to most antistaphylococcal antibiotics, have acquired new antibiotic resistance determinants, to gentamicin and ofloxacin for instance. v."}